Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma

Diseases of the Esophagus

Volumn 16, Issue 2, 2003, Pages 94-98

  Noguchi, T ^a   Moriyama, H ^a   Wada, S ^a   Takeno, S ^a   Wakisaka, M ^a   Mori, H ^a   Uchida, Y ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Chemoradiotherapy; Esophageal carcinoma; Survival; T4 cancer; Trimodal therapy

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DIAZEPAM; FLUOROURACIL; METOCLOPRAMIDE;

ABDOMINAL ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CATHETER INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HEART INFARCTION; HUMAN; LIVER FAILURE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURGICAL MORTALITY; TUMOR REGRESSION; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 0043065487     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2003.00304.x     Document Type: Article

References (21)

1. Guili R, Gignoux M. Treatment of carcinoma of the esophagus. Retrospective study of 2400 patients. Ann Surg 1980; 192: 44-52.
2. Earlam R, Cunha-Melo J R. Oesophageal squamous cell carcinoma. A critical review of surgery. Br J Surg 1980; 67: 381-90.
3. Müller J M, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
4. Japanese Research Society for Esophageal Diseases. ISDE News 1987; 2: 2.
5. Katlic M R, Wilkins E W, Grillo H C. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 1990; 99: 929-38.
6. Richmond J, Seydel H G, Bae Y, Lewis J, Burdakin J, Jacobsen G. Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys 1987; 13: 1617-20.
7. John M J, Flam M S, Mowry P A, et al. Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 1989; 63: 2397-403.
8. Seitz J F, Giovannini M, Padaut-Cesana J, et al. Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer 1990; 66: 214-9.
9. Orringer M B, Forastiere A A, Perez-Tamayo C, Urba S, Takasugi B J, Bromberg J. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma. Ann Thorac Surg 1990; 49: 348-55.
10. Hennequin C, Gayet B, Sauvanet A, et al. Impact on survival of surgery after concomitant chemoradiation for locally advanced cancers of the esophagus. Int J Radiat Oncol Biol Phys 2001; 49: 657-64.
11. Forastiere A A, Orringner M B, Perez-Tamayo C, Urba S G, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 1993; 11: 1118-23.
12. Slater M S, Holland J, Faigel D O, Sheppard B C, Deveney C W. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001; 181: 440-4.
13. Yano M, Tsujinaka T, Shiozaki H, et al. Concurrent chemotherapy (5-fluorouracil and cisplatin) and radiation therapy followed by surgery for T4 squamous cell carcinoma of the esophagus. J Surg Oncol 1999; 70: 25-32.
14. Ancona E, Ruol A, Castoro C, et al. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, anyN, M0) squamous cell carcinoma of the thoracic esophagus. Ann Surg 1997; 226: 714-24.
15. Naunheim K S, Petruska P J, Roy T S, et al. Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 1992; 103: 887-95.
16. Wolfe W G, Vaughn A L, Seigler H F, Hathorn J W, Leopold K A, Duhaylongsod F G. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy. J Thorac Cardiovasc Surg 1993; 105: 749-56.
17. Stahl M, Wilke H, Fink U, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: Interim analysis of a phase II trial. J Clin Oncol 1996; 14: 829-37.
18. Takeno S, Noguchi T, Takahashi Y, Kikuchi R, Uchida Y, Yokoyama S. Immunohistochemical and clinicopathologic analysis of response to neoadjuvant therapy for esophageal squamous cell carcinoma. Dis Esophagus 2001; 14: 149-54.
19. Nygaard K, Hagen S, Hansen H S, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-10.
20. Le Prise E, Etienne P L, Meunier B, et al. A randomized study of chemotherapy, radiation therapy and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-84.
21. Jones D R, Detterbeck F C, Egan T M, Parker L A Jr, Bernard S A, Tepper J E. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 1997; 64: 185-92.